» Articles » PMID: 25106887

Synthesis and Evaluation of Naphthoflavones As a New Class of Non Purine Xanthine Oxidase Inhibitors

Overview
Specialty Biochemistry
Date 2014 Aug 10
PMID 25106887
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In view of reported xanthine oxidase inhibitory potential of naphthopyrans and flavones, naphthoflavones as hybrids of the two were designed, synthesized and evaluated for in vitro xanthine oxidase inhibitory activity in the present study. The results of the assay revealed that the naphthoflavones possess promising inhibitory potential against the enzyme with IC50 values ranging from 0.62 to 41.2 μM. Structure activity relationship indicated that the nature and placement of substituents on the phenyl ring at 2nd position remarkably influences the inhibitory activity. Substitution of halo and nitro groups at ortho and para position of the phenyl ring (2nd position) remarkably favored the activity. NF-4 with p-fluoro phenyl ring was the most potent inhibitor with IC50 value of 0.62 μM. Enzyme kinetics study was also performed to investigate the inhibition mechanism and it was found that the naphthoflavones displayed mixed type inhibition. The basis of significant inhibition of xanthine oxidase by NF-4 was rationalized by molecular modeling studies.

Citing Articles

Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure-activity relationship and molecular docking studies (2018-2024).

Singh A, Debnath R, Chawla V, Chawla P RSC Med Chem. 2024; 15(6):1849-1876.

PMID: 38911168 PMC: 11187568. DOI: 10.1039/d4md00072b.


Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials.

Singh A, Singh K, Sharma A, Kaur K, Chadha R, Bedi P RSC Med Chem. 2023; 14(11):2155-2191.

PMID: 37974965 PMC: 10650961. DOI: 10.1039/d3md00316g.


Inhibition of Xanthine Oxidase by 4-nitrocinnamic Acid: and Investigations and Docking Simulations.

Chen J, Yu S, He Z, Zhu D, Cai X, Ruan Z Curr Pharm Biotechnol. 2023; 25(4):477-487.

PMID: 37345239 DOI: 10.2174/1389201024666230621141014.


Benzoflavone derivatives as potent antihyperuricemic agents.

Singh J, Mal G, Kaur G, Gupta M, Singh A, Nepali K Medchemcomm. 2019; 10(1):128-147.

PMID: 30931089 PMC: 6399681. DOI: 10.1039/c8md00512e.


Pharmacology and Clinical Drug Candidates in Redox Medicine.

Dao V, Casas A, Maghzal G, Seredenina T, Kaludercic N, Robledinos-Anton N Antioxid Redox Signal. 2015; 23(14):1113-29.

PMID: 26415051 PMC: 4657508. DOI: 10.1089/ars.2015.6430.